Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Anixa Biosciences Inc | exhibit32_2.htm |
| EX-32.1 - EXHIBIT 32.1 - Anixa Biosciences Inc | exhibit32_1.htm |
| EX-31.2 - EXHIBIT 31.2 - Anixa Biosciences Inc | exhibit31_2.htm |
| EX-31.1 - EXHIBIT 31.1 - Anixa Biosciences Inc | exhibit31_1.htm |
| EX-21 - EXHIBIT 21 - Anixa Biosciences Inc | exhibit21.htm |
| 10-K - FORM 10-K - Anixa Biosciences Inc | form10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Post-Effective Amendment No. 2 to the Registration Statement on Form S-1 on Form S-3 (No. 333-193869), Amendment No. 1 to the Registration Statement on Form S-3 (No. 333-206782), Registration Statements on Form S-3 (Nos. 333-220963 and 333-217060) and the Registration Statement on Form S-8 (No. 333-227653) of Anixa Biosciences, Inc. (the “Company”) of our report dated January 11, 2019 relating to our audits of the Company’s consolidated financial statements as of October 31, 2018 and 2017, and for each of the years then ended, included in the Company’s Annual Report on Form 10-K for the year ended October 31, 2018.
/s/ Haskell & White LLP
HASKELL & WHITE LLP
Irvine, California
January 11, 2019